October 13, 2016
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA, formerly HDMA) will host its annual Traceability Seminar November 9–11, 2016, at the Renaissance Washington, DC Downtown Hotel. The seminar will host supply chain leaders — including distributors, manufacturers, pharmacists, third-party logistics providers — as well as federal/state regulators to discuss upcoming milestones and lessons learned as they continue to implement the Drug Supply Chain Security Act (DSCSA).
FDA’s Connie Jung, RPh, PhD, Acting Associate Director for Policy and Communications, Office of Drug Security, Integrity and Recalls, will deliver a keynote presentation on the DSCSA guidance the agency has provided, how FDA is preparing for the implementation milestones and the agency’s expectations for the pharmaceutical supply chain as it steadily approaches the 2023 completion date.
Another highlight of the seminar will be a presentation of the results from HDA’s Pilot Study for Saleable Returns, which was conducted earlier this year to further understand the operational impact of the DSCSA’s 2019 requirements for distributors to verify serialized saleable returns from customers. A group of industry experts from various manufacturers and distributors conducted a study of nine real-life scenarios that would allow the pharmaceutical supply chain to comply with the requirements related to the 2019. HDA will outline the workable solutions that were identified through the pilot project.
“Implementing the DSCSA has been an incredibly collaborative effort on behalf of supply chain stakeholders and state and federal regulators. Our Traceability Seminar provides a unique opportunity for distributors, manufacturers, dispensers, solutions providers and regulators to meet in one place to share what they have learned and to identify new opportunities to work together,” said Perry Fri, HDA’s Executive Vice President, Industry Relations, Membership and Education, and Chief Operating Officer of the HDA Research Foundation.
Additional sessions will touch on meeting global traceability requirements, as well as perspectives from the retail/pharmacy community and technology experts on their priorities for implementation.
A full agenda, registration information and participating sponsors can be found on HDA’s website.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.